# Valproate Alone or in Combination With Quetiapine for Severe COVID-19 Pneumonia With Agitated Delirium

> **NCT04513314** · PHASE4 · WITHDRAWN · sponsor: **University of Miami**

## Conditions studied

- Covid19
- Hyperactive Delirium
- Pneumonia, Viral

## Interventions

- **DRUG:** Valproate
- **DRUG:** Quetiapine
- **OTHER:** Standard of Care

## Key facts

- **NCT ID:** NCT04513314
- **Lead sponsor:** University of Miami
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2023-03-28
- **Primary completion:** 2023-03-28
- **Final completion:** 2023-03-28
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** coronavirus omicron variant infection typically not associated with delirium and agitation severely hampered recruitment.
- **Last updated:** 2023-03-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04513314

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04513314, "Valproate Alone or in Combination With Quetiapine for Severe COVID-19 Pneumonia With Agitated Delirium". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04513314. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*